Photo from wikipedia
Immunotherapies activate T cells to destroy tumours, but the approach has failed in some brain cancers. A strategy to improve migration of T cells across the blood–brain barrier could overcome… Click to show full abstract
Immunotherapies activate T cells to destroy tumours, but the approach has failed in some brain cancers. A strategy to improve migration of T cells across the blood–brain barrier could overcome this limitation.A synthetic ligand enhances T-cell binding to brain endothelial cells.
Keywords:
brain cancer;
cells engineered;
engineered home;
home brain;
brain
Journal Title: Nature
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!